An international clinical trial is investigating the potential of a finger-prick blood test for diagnosing Alzheimer's disease.
The Bio-Hermes-002 study is currently underway in the United Kingdom, the United States, and Canada. It has recruited 1,000 participants aged 60 and older.
Researchers involved in the trial aim to identify specific biomarkers within the blood that indicate the presence of the degenerative condition.